Investigates antioxidant activity and quality characteristics of tofu with low molecular fish collagen, indicating its potential for commercial use.
This study investigated the antioxidant activity (2,2’-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) [ABTS], 1,1-diphenyl-2-picrylhydrazyl [DPPH]) as well as the general and quality characteristics of tofu (traditional oriental soybean curd) supplemented with low molecular fish collagen (LMFC). The yield of tofu supplemented with 0% (Control), 10%, and 20% collagen decreased significantly to 164.79%, 147.70%, and 140.49%, respectively (p < 0.05). Antioxidant activity was assessed using ABTS and DPPH, showing a significant increase (p < 0.05). The pH values were 6.37, 6.32, and 6.33, with a significant decrease at 10% supplementation (p < 0.05), while there was no significant difference between 10% and 20% (p > 0.05). Crude protein content was 10.77%, 10.78%, and 11.38%, with no significant difference between control and 10% (p > 0.05) but a significant increase at 20%. Crude ash content was 1.60%, 1.37%, and 1.44%, with no significant difference between 10% and 20% (p > 0.05), but a significant decrease compared to the control. Texture hardness and chewiness decreased significantly (p < 0.05), while elasticity showed no significant difference (p > 0.05). In Hunter color analysis, the L value (brightness) decreased significantly (p < 0.05). The b value (yellowness) and ΔE (overall color change) increased significantly (p < 0.05), but the a value (redness) showed no significant (p > 0.05) difference. This study suggests that tofu supplemented with LMFC exhibited significant differences in antioxidant activity and general characteristics, indicating potential for commercial development.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: